BIOSEARCH TECHNOLOGIES, INC.

Federal contract awards won by BIOSEARCH TECHNOLOGIES, INC. (UEI NX7NLJUNSEU6), 2022–2024 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

4
awards
1
expiring in 12 months
1
agency

How their work has changed

Their work has changed a lot over the last two years.

Biggest change: In-Vitro Diagnostic Substance Manufacturing (325413) went from 10% of their contracts to 57%.

Industry (NAICS)2 years beforeLast 2 years
In-Vitro Diagnostic Substance Manufacturing (325413)10%57%
All Other Basic Organic Chemical Manufacturing (325199)60%29%
Biological Product (except Diagnostic) Manufacturing (325414)10%0%
Research and Development in Biotechnology (except Nanobiotechnology) (541714)10%0%
Analytical Laboratory Instrument Manufacturing (334516)10%14%

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 9, 2026. Shown only for companies with at least 5 contracts in each period.

Category award history

23 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: BECKMAN COULTER, INC took Department of Defense 325413 work from BIOSEARCH TECHNOLOGIES, INC. (Sep 30, 2026).

Agencies buying from BIOSEARCH TECHNOLOGIES, INC.

Department of Health and Human Services (4)

What BIOSEARCH TECHNOLOGIES, INC. has provided

325199 — ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING (2)325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING (2)

Awards

GMP MANUFACTURING OF CDC FLUSC2 MULTIPLEX EUAAND IVD KITS
Department of Health and Human Services · $763,453 · Sep 27, 2024
PRIMER PROBES
Department of Health and Human Services · $258,768 · Aug 17, 2023
SARS-COV2 INFLUENZA MULTIPLEX
Department of Health and Human Services · $757,634 · Apr 26, 2023
PRIMER PROBES
Department of Health and Human Services · $626,838 · May 11, 2022